Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
15 Apr 2016 ELCC 2016 Press Release: Studies Confirm Benefit of Plasma Genotyping to Predict Treatment Benefit in Patients with Non-Small-Cell Lung Cancer Lung and other thoracic tumours
15 Apr 2016 ELCC 2016 Press Release: Patients with EGFR Expressing Non-Small-Cell Lung Cancer Benefit Most from Necitumumab Added to Chemotherapy Lung and other thoracic tumours - Anticancer agents & Biologic therapy
14 Apr 2016 ELCC 2016 News: Elderly Patients with Malignant Pleural Mesothelioma Should Not Be Excluded from Extended Pleurectomy Decortication Lung and other thoracic tumours
14 Apr 2016 ELCC 2016 News: Possibility of Overtreatment Linked to Clinically-Diagnosed Early-Stage Lung Cancer Lung and other thoracic tumours
14 Apr 2016 ELCC 2016 Press Release: Immunotherapy With Live Bacterium Improves Response Rate in Malignant Pleural Mesothelioma Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
14 Apr 2016 ELCC 2016 Press Release: Osimertinib Given as First-line Treatment May Alter Biology of EGFR-Mutated Non-Small-Cell Lung Cancer Lung and other thoracic tumours - Anticancer agents & Biologic therapy
08 Apr 2016 FDA Allows Marketing of First-of-Kind Tissue Containment System for Use With Certain Laparoscopic Power Morcellators in Select Patients
07 Apr 2016 EMA Recommends Granting a Marketing Authorisation for Generic Palonosetron Palliative and supportive care
05 Apr 2016 EMA Adopts an Extension to the Indications for Nivolumab Melanoma - Cancer Immunology and Immunotherapy
05 Apr 2016 NICE Develops a Medtech Innovation Briefing on Selective Internal Radiation Therapy Gastrointestinal cancers
04 Apr 2016 EMA Adopts a New Indication for Eribulin Sarcomas - Anticancer agents & Biologic therapy
04 Apr 2016 EMA Recommends Granting a Conditional Marketing Authorisation for Daratumumab Haematologic malignancies - Anticancer agents & Biologic therapy
29 Mar 2016 MYC Overexpressed Triple Negative Breast Cancer Breast cancer - Translational research
25 Mar 2016 Combined Inhibition of DDR1 and Notch Signalling for KRAS-Driven Lung Adenocarcinoma Translational research - Lung and other thoracic tumours
24 Mar 2016 ISO Renews Standards For Safer Medication Bioethics, legal and economic issues